INGREZZA - For the treatment of chorea associated with Huntington's Disease (HD) TOOLKIT & RESOURCESkatrina4384Sep 26, 20231 min readFind out more here:INGREZZA HDC Launch Toolkit_FINAL.pdf
Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
Comments